These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 23999999)

  • 1. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
    Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
    Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
    J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
    Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
    Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
    Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
    Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling plasma microRNA in nasopharyngeal carcinoma with deep sequencing.
    Wang HY; Yan LX; Shao Q; Fu S; Zhang ZC; Ye W; Zeng YX; Shao JY
    Clin Chem; 2014 May; 60(5):773-82. PubMed ID: 24563490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
    Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.
    Liu X; Zhang X; Zhang Z; Chang J; Wang Z; Wu Z; Wang C; Sun Z; Ge X; Geng R; Tang W; Dai C; Lin Y; Lin F; Sun M; Jia W; Xue W; Ji J; Hu Y; Qin G; Li J
    Int J Cancer; 2017 Nov; 141(10):2093-2102. PubMed ID: 28722210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
    Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
    Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma.
    Tang JF; Yu ZH; Liu T; Lin ZY; Wang YH; Yang LW; He HJ; Cao J; Huang HL; Liu G
    Asian Pac J Cancer Prev; 2014; 15(18):7575-81. PubMed ID: 25292031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT.
    Zhang Z; Huang J; Wang G; Jin F; Zheng J; Xiao H; Lei L; Luo J; Chen C
    BMC Cancer; 2020 Mar; 20(1):183. PubMed ID: 32131777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA expression profiling of nasopharyngeal carcinoma.
    Li T; Chen JX; Fu XP; Yang S; Zhang Z; Chen KhH; Li Y
    Oncol Rep; 2011 May; 25(5):1353-63. PubMed ID: 21373758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
    Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
    Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
    [No Abstract]   [Full Text] [Related]  

  • 19. Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.
    Plieskatt JL; Rinaldi G; Feng Y; Levine PH; Easley S; Martinez E; Hashmi S; Sadeghi N; Brindley PJ; Bethony JM; Mulvenna JP
    J Transl Med; 2014 Jan; 12():3. PubMed ID: 24393330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miR-214-3p predicts nasopharyngeal carcinoma recurrence or metastasis.
    Wang J; Xu Y; Wang J; Ying H
    Clin Chim Acta; 2020 Apr; 503():54-60. PubMed ID: 31926154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.